BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32558350)

  • 21. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis.
    Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y
    Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
    Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of Long Non-coding RNA TTN-AS1 Inhibits Hepatocellular Carcinoma Progression by the MicroRNA-134/ITGB1 Axis.
    Huang Y; Chu P; Bao G
    Dig Dis Sci; 2021 Nov; 66(11):3916-3928. PubMed ID: 33387127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
    Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
    J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
    Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
    J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway.
    Yang J; Li C; Li H; E C
    J Cell Physiol; 2019 Aug; 234(10):18415-18422. PubMed ID: 30908634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
    Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
    Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1).
    Mou Y; Sun Q
    Bioengineered; 2022 Jan; 13(1):746-758. PubMed ID: 34859735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
    Wang YG; Liu J; Shi M; Chen FX
    J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
    Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
    Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A.
    Zhou C; Chen Z; Peng C; Chen C; Li H
    Cancer Biother Radiopharm; 2021 Mar; 36(2):211-219. PubMed ID: 32391716
    [No Abstract]   [Full Text] [Related]  

  • 32. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
    Teng F; Zhang JX; Chang QM; Wu XB; Tang WG; Wang JF; Feng JF; Zhang ZP; Hu ZQ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):235. PubMed ID: 33168027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
    Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
    Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
    Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
    J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
    Dong H; Jian P; Yu M; Wang L
    J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC.
    Habashy DA; Hamad MHM; Ragheb M; Khalil ZA; El Sobky SA; Hosny KA; Esmat G; El-Ekiaby N; Fawzy IO; Abdelaziz AI
    Life Sci; 2022 Dec; 310():121075. PubMed ID: 36243115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway.
    Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J
    Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis.
    Peng Z; Ouyang X; Wang Y; Fan Q
    BMC Mol Cell Biol; 2022 Apr; 23(1):21. PubMed ID: 35468721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
    Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
    J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
    Zhang R; Jiang YY; Xiao K; Huang XQ; Wang J; Chen SY
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):87-96. PubMed ID: 31758243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.